Latest news with #BillRoberts
CTV News
20-07-2025
- General
- CTV News
More than 100-year-old home destroyed in North Kentville, N.S., fire
A home on Aldershot Road in North Kentville, N.S., was destroyed by a fire in the early hours of Sunday, July 20, 2025. (Source: Bill Roberts) A more than 100-year-old home was destroyed in a fire early Sunday morning in North Kentville, N.S. The Kentville Volunteer Fire Department was called around 2 a.m. to the fire on Aldershot Road. Deputy Fire Chief Ian Fairclough said four people were home at the time and were able to safely escape. 'The fire had spread throughout the home within about 15 minutes of it being reported,' Fairclough said in an email to CTV News. 'The bulk of the fire was knocked down within an hour, but it took significant time for overhaul to find all hidden fire left in the walls, ceilings and floors, as the amount of damage meant it was not safe to be inside most of the structure.' He said there were approximately 40 firefighters on scene, with the last unit leaving around 8 a.m. One firefighter was assessed on scene for a minor injury, but did not require hospitalization. The home was a total loss. The cause of the fire is under investigation, but Fairclough said it is not believed to be suspicious. The fire itself started outside the home before spreading. The building and property are being secured by the insurance company. He said the residents are taking with family until they can find other accommodations through their insurance company. For more Nova Scotia news, visit our dedicated provincial page
Cision Canada
25-06-2025
- Business
- Cision Canada
Acclaro Medical Receives Health Canada Approval for UltraClear® 2910 nm Cold Ablative Fiber Laser
~ Groundbreaking Laser Featuring Superficial 3DMIRACL ® and First-of-its-Kind Laser Coring ™ ~ Acclaro Medical Partners with Xcite Technology, North America's Leading Provider of Revolutionary Energy-Based Skin Technologies, to Drive Canadian Distribution Efforts SMITHFIELD, R.I., June 25, 2025 /CNW/ -- Acclaro Medical, a global innovator in advanced energy-based technologies for aesthetic, ophthalmic and surgical markets, is proud to announce the approval of its flagship UltraClear ® 2910 nm fiber laser by Health Canada. This clearance marks a significant expansion for the company and brings one of the industry's most advanced skin rejuvenation platforms to Canadian provider and patients. Acclaro Medical has also partnered with Xcite Technology, a recognized leader in aesthetic energy-based device distribution, to spearhead commercialization efforts across Canada. Engineered with proprietary MID IR Fiber Laser and 3DIntelliPulse™ technology, UltraClear is the world's first and only 2910 nm cold ablative fiber offering precise, customizable treatments that address superficial to deep skin concerns with minimal downtime and exceptional patient comfort. Its unique treatment modes, including 3DMIRACL ® for gentle resurfacing and Laser Coring™ to help reverse a wide range of telltale signs associated with aging and gravity, set a new standard for what's possible in total skin health. "The approval of our UltraClear in Canada as the first and only 2910 nm fiber laser marks a significant milestone in our steadfast commitment to bringing breakthrough innovation to Canadian aesthetic providers and their patients," said Helen Fang, CEO, Acclaro Medical. "Across Acclaro Medical, we are proud of our shared vision to deliver category-defining solutions for a full range of patient-friendly treatment options tailored to their needs, lifestyles and skin types." As the exclusive Canadian distributor, Xcite Technologies will bring UltraClear to aesthetic clinics nationwide. With a strong track record in introducing disruptive technologies to the market, Xcite is ideally positioned to support clinical adoption and elevate standards in laser-based treatments. "UltraClear is unlike anything currently available," said Bill Roberts, CEO of Xcite Technologies. "The 2910 nm cold ablative fiber laser combined with proprietary Laser Coring technology delivers a level of precision, depth, and patient comfort that truly redefines what's possible in skin rejuvenation. This is a major step forward for Canadian providers looking to offer high-efficacy treatments with minimal downtime and broad patient appeal." About Acclaro Medical Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL ® and Laser Coring ® skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit or contact Xcite Technologies for regional availability. Xcite Technologies is Canada's leading distributor of advanced medical aesthetic technologies, known for bringing the most innovative, clinically proven aesthetic solutions. With a consistent track record of launching state-of-the-art platforms like UltraClear, Xcite remains at the forefront of aesthetic medicine—ensuring Canadian providers have access to the latest global advancements in energy-based treatments that address the full spectrum of skin types and concerns.
Yahoo
25-06-2025
- Business
- Yahoo
Acclaro Medical Receives Health Canada Approval for UltraClear® 2910 nm Cold Ablative Fiber Laser
~ Groundbreaking Laser Featuring Superficial 3DMIRACL® and First-of-its-Kind Laser Coring™ Treatments Now Available in Canada ~ Acclaro Medical Partners with Xcite Technology, North America's Leading Provider of Revolutionary Energy-Based Skin Technologies, to Drive Canadian Distribution Efforts SMITHFIELD, R.I., June 25, 2025 /CNW/ -- Acclaro Medical, a global innovator in advanced energy-based technologies for aesthetic, ophthalmic and surgical markets, is proud to announce the approval of its flagship UltraClear® 2910 nm fiber laser by Health Canada. This clearance marks a significant expansion for the company and brings one of the industry's most advanced skin rejuvenation platforms to Canadian provider and patients. Acclaro Medical has also partnered with Xcite Technology, a recognized leader in aesthetic energy-based device distribution, to spearhead commercialization efforts across Canada. Engineered with proprietary MID IR Fiber Laser and 3DIntelliPulse™ technology, UltraClear is the world's first and only 2910 nm cold ablative fiber offering precise, customizable treatments that address superficial to deep skin concerns with minimal downtime and exceptional patient comfort. Its unique treatment modes, including 3DMIRACL® for gentle resurfacing and Laser Coring™ to help reverse a wide range of telltale signs associated with aging and gravity, set a new standard for what's possible in total skin health. "The approval of our UltraClear in Canada as the first and only 2910 nm fiber laser marks a significant milestone in our steadfast commitment to bringing breakthrough innovation to Canadian aesthetic providers and their patients," said Helen Fang, CEO, Acclaro Medical. "Across Acclaro Medical, we are proud of our shared vision to deliver category-defining solutions for a full range of patient-friendly treatment options tailored to their needs, lifestyles and skin types." As the exclusive Canadian distributor, Xcite Technologies will bring UltraClear to aesthetic clinics nationwide. With a strong track record in introducing disruptive technologies to the market, Xcite is ideally positioned to support clinical adoption and elevate standards in laser-based treatments. "UltraClear is unlike anything currently available," said Bill Roberts, CEO of Xcite Technologies. "The 2910 nm cold ablative fiber laser combined with proprietary Laser Coring technology delivers a level of precision, depth, and patient comfort that truly redefines what's possible in skin rejuvenation. This is a major step forward for Canadian providers looking to offer high-efficacy treatments with minimal downtime and broad patient appeal." About Acclaro Medical Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL® and Laser Coring® skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit or contact Xcite Technologies for regional availability. About Xcite Technologies Xcite Technologies is Canada's leading distributor of advanced medical aesthetic technologies, known for bringing the most innovative, clinically proven aesthetic solutions. With a consistent track record of launching state-of-the-art platforms like UltraClear, Xcite remains at the forefront of aesthetic medicine—ensuring Canadian providers have access to the latest global advancements in energy-based treatments that address the full spectrum of skin types and concerns. Media Contact:Nadine ToskTosk Communications for Acclaro Medicalnadinepr@ 504.453.8344 View original content to download multimedia: SOURCE Acclaro Corporation View original content to download multimedia:
CTV News
13-05-2025
- Climate
- CTV News
RV, home total losses after Lakeville, N.S., fire
An RV and house are pictured on fire in Lakeville, N.S., on May 13, 2025. (Courtesy: Bill Roberts)
CTV News
12-05-2025
- CTV News
Vehicle travelling against traffic before fatal collision: N.S. RCMP
Emergency crews remained on scene of a fatal collision in Falmouth, N.S., in the early hours of Sunday, May 11, 2025. (Source: Bill Roberts)
